Avagacestat is an oral gamma secretase inhibitor designed for selective inhibition of amyloid beta synthesis.
This report contains market size and forecasts of Avagacestat in global, including the following market information:
Global Avagacestat Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Avagacestat Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Avagacestat companies in 2021 (%)
The global Avagacestat market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Avagacestat include Santa Cruz Biotechnology, Selleck Chemicals, Adooq Bioscience, Bio-Techne, Cayman Chemical, APExBIO Technology, Abcam, Biorbyt and Toronto Research Chemicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Avagacestat manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Avagacestat Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Avagacestat Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Avagacestat Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Avagacestat Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Avagacestat Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Avagacestat Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Avagacestat revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Avagacestat revenues share in global market, 2021 (%)
Key companies Avagacestat sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Avagacestat sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Santa Cruz Biotechnology
Selleck Chemicals
Adooq Bioscience
Bio-Techne
Cayman Chemical
APExBIO Technology
Abcam
Biorbyt
Toronto Research Chemicals
Creative Enzymes
MyBiosource
Xcess Biosciences
AbMole
BioVision
Aladdin
TargetMol